CANCER FUND
Overview
CANCER FUND is a US-based venture capital firm founded in 2018 that focuses on impact investments in startup companies launching new cancer therapies, diagnostics, and preventions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| March Biosciences | Oct 2024 | Series A | - |
| Reglagene | Dec 2023 | Series A Extension | Lead |
| AOA Dx | Jul 2023 | Series A | Co-investor |
| NXgenPort | Nov 2024 | Seed | Co-investor |
| Cellens Inc. | Dec 2025 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is CANCER FUND based?
CANCER FUND is headquartered in Phoenix, Arizona, United States.
When was CANCER FUND founded?
CANCER FUND was founded in 2018.
How many portfolio companies does CANCER FUND have?
CANCER FUND has 8 portfolio companies in Caplight's dataset.
What are some companies in CANCER FUND's portfolio?
Portfolio companies visible on Caplight include March Biosciences, Reglagene, AOA Dx, NXgenPort, Cellens Inc..
What was CANCER FUND's most recent investment shown here?
CANCER FUND's most recent investment in this portfolio sample was in Cellens Inc. in 2025.
What sectors does CANCER FUND focus on?
CANCER FUND focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does CANCER FUND focus on?
CANCER FUND typically invests at the Early stage.
What is CANCER FUND's AUM?
CANCER FUND's assets under management are estimated between $10.0M and $30.0M.